Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GPhA Seeks Change On Medicaid “Best Price” For “Authorized” Generics

Executive Summary

The Generic Pharmaceutical Association's challenge to "authorized" generics includes pushing for a change in how the Medicaid "best price" for a branded product and its authorized generic are reported

You may also be interested in...



Duragesic Competition Could Add To Mylan’s “Authorized” Generics Fight

The anticipated launch of an "authorized" generic of J&J's Duragesic could give Mylan further ammunition in its ongoing fight against such products

Duragesic Competition Could Add To Mylan’s “Authorized” Generics Fight

The anticipated launch of an "authorized" generic of J&J's Duragesic could give Mylan further ammunition in its ongoing fight against such products

Congress Needs To Review “Authorized” Generics, Hatch And Waxman Agree

Congress will likely have to look at the issue of "authorized" generics, Sen. Orrin Hatch (R-Utah) and Rep. Henry Waxman (D-Calif.) said during an Oct. 6 Drug & Device Dialogue audio conference sponsored by FDC Reports and Polidais LLC

Related Content

UsernamePublicRestriction

Register

ID1130879

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel